Critics of the South African government argue that it has done too little too late to secure vaccines, and that it doesn't have a proper plan in place for rollout.
Many countries cannot afford to buy existing COVID-19 vaccines, a collective approach is needed.
It’s unlikely South Africa will have a substantial number of vaccines until the second half of this year. Most of the vaccines produced in Europe or America have been bought by other countries.
A waiver on some intellectual property rules at the WTO for COVID-19 vaccines would ensure more equitable access, but wouldn't solve all the problems facing developing countries.
Unprecedented efforts are driving the global push for a safe and effective vaccine. If and when we have one (or more), here's how it's likely to be rolled out in Australia.
Side agreements signed by some wealthy nations threaten to undercut global efforts to ensure a fairly equitable worldwide vaccination effort.
The Trump administration wants to go it alone when it comes to vaccine development and distribution. What does this mean for the U.S. and the world?
With $1 billion in advance purchase agreements for COVID-19 vaccines, Canada has joined the vaccine nationalists: rich countries buying up more than half the global short-term supply of vaccine.
Australia's contribution to the global COVAX initiative helps secure future vaccines. Here's the full field of candidates.
More than 170 countries have signed up to the Global Access (COVAX) initiative, but vaccine hoarding has already begun by many wealthy countries — leaving poorer nations potentially in the lurch.